US President Trump has taken aim at Europe for undercharging for medicine. But raising prices in Europe would face strong ...

Artificial intelligence (AI) is reshaping the pharmaceutical industry ... a Swiss biotechnology company spun out of ETH Zurich, and co-founded Nymirum, a private venture backed biotechnology ...

An epidemiological market study commissioned by Curatis Holding AG (SIX:CURN, "Curatis") shows that the target patient group is substantially larger than previous estimates. In the US alone, over 150, ...

Global events can have a profound impact on all industries, with the pharmaceutical industry particularly at risk due to an extensive and international supply chain. From chemicals to API ...

ETH Zurich supports interdisciplinary collaborations of researchers both within institutional networks, as well as with other scientific partners and industry. The aim is always to expand the ...

For the second year in a row, the pharmaceutical industry has dipped further out of favor with patient groups around the world. The industry’s reputation surged during the COVID-19 pandemic ...

The automation company Festo and ETH Zurich are creating soft robotic actuators with muscle ... through collaboration and exchange with industry, policymakers, public administration, and society at ...

Medicines and chemicals are huge exports for European Union countries. That makes the sector a weak spot as trade tensions drag on. By Jeanna Smialek Liz Alderman and Melissa Eddy Jeanna Smialek ...

about the impact geopolitical changes in Europe might have on the bio/pharmaceutical industry. Political shifts in the United Kingdom and Europe may have a negative impact on research efforts for gene ...

Kennedy Jr. has vilified the drug industry’s profits and questioned the safety of its products. Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for ...